Blockage of tissue factor ameliorates the lesion of laser-induced choroidal neovascularization in mice

Experimental Eye Research

Volumn 127, Issue , 2014, Pages 117-123

  Wang, Li ^a   Yang, Zhongkai ^b   Yu, Ying ^a   Cui, Chen ^a   Guan, Huaijin ^a   Chen, Hui ^a  

^a NANTONG UNIVERSITY   (China)

^b Department of Ophthalmology Xinhua Hospital ^*  (China)

Author keywords

Anti TF monoclonal antibody; Choroidal neovascularization; Mouse; Tissue factor

Indexed keywords

ANGIOGENESIS INHIBITOR; CELL PROTEIN; F4 80 PROTEIN; MONOCLONAL ANTIBODY; PROTEIN ANTIBODY; THROMBOPLASTIN; TISSUE FACTOR ANTIBODY; UNCLASSIFIED DRUG; VASCULOTROPIN; BLOCKING ANTIBODY; MESSENGER RNA; PROTEIN; PROTEIN F4 80; TISSUE FACTOR MONOCLONAL ANTIBODY;

ADULT; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIANGIOGENIC ACTIVITY; ARTICLE; BRAIN TISSUE; CONTROLLED STUDY; DRUG EFFECT; DRUG EFFICACY; HEART; HISTOPATHOLOGY; KIDNEY PARENCHYMA; LASER COAGULATION; LIVER; MOUSE; MOUSE MODEL; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; SUBRETINAL NEOVASCULARIZATION; EXPERIMENTAL EYE DISEASE; INCIDENCE; LIVER PARENCHYMA; LOW LEVEL LASER THERAPY; QUANTITATIVE ANALYSIS; RETINA DETACHMENT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; UPREGULATION; WESTERN BLOTTING;

ANTI-TF MONOCLONAL ANTIBODY; CHOROIDAL NEOVASCULARIZATION; MOUSE; TISSUE FACTOR;

ANIMALS; ANTIBODIES, BLOCKING; ANTIBODIES, MONOCLONAL; ANTIGENS, DIFFERENTIATION; BLOTTING, WESTERN; CAPILLARY PERMEABILITY; CHOROIDAL NEOVASCULARIZATION; DISEASE MODELS, ANIMAL; FLUORESCEIN ANGIOGRAPHY; IMMUNOHISTOCHEMISTRY; IMMUNOTHERAPY; INTRAVITREAL INJECTIONS; LASER COAGULATION; MICE; MICE, INBRED C57BL; REAL-TIME POLYMERASE CHAIN REACTION; THROMBOPLASTIN; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 84905381636     PISSN: 00144835     EISSN: 10960007     Source Type: Journal    
DOI: 10.1016/j.exer.2014.07.006     Document Type: Article

References (48)

1. Abe K., Shoji M., Chen J., Bierhaus A., Danave I., Micko C., Casper K., Dillehay D.L., Nawroth P.P., Rickles F.R. Regulation of vascular endothelial growth factor production and angiogenesis by the cytoplasmic tail of tissue factor. Proc. Natl. Acad. Sci. U. S. A. 1999, 96(15):8663-8668.
2. Ahamed J., Ruf W. Protease-activated receptor 2-dependent phosphorylation of the tissue factor cytoplasmic domain. J.Biol. Chem. 2004, 279(22):23038-23044.
3. Arias L., Caminal J.M., Rubio M., Pujol O., Arruga J. Retinal pigment epithelial tears after intravitreal bevacizumab injection for predominantly classic choroidal neovascularization. Eur. J. Ophthalmol. 2007, 17(6):992-995.
4. Bakall B., Folk J.C., Boldt H.C., Sohn E.H., Stone E.M., Russell S.R., Mahajan V.B. Aflibercept therapy for exudative age-related macular degeneration resistant to bevacizumab and ranibizumab. Am. J. Ophthalmol. 2013, 156(1):15-22 e11.
5. Belting M., Dorrell M.I., Sandgren S., Aguilar E., Ahamed J., Dorfleutner A., Carmeliet P., Mueller B.M., Friedlander M., Ruf W. Regulation of angiogenesis by tissue factor cytoplasmic domain signaling. Nat. Med. 2004, 10(5):502-509.
6. Belting M., Ahamed J., Ruf W. Signaling of the tissue factor coagulation pathway in angiogenesis and cancer. Arterioscler. Thromb. Vasc. Biol. 2005, 25(8):1545-1550.
7. Bluff J.E., Brown N.J., Reed M.W., Staton C.A. Tissue factor, angiogenesis and tumour progression. Breast Cancer Res. 2008, 10(2):204.
8. Bora P.S., Hu Z., Tezel T.H., Sohn J.H., Kang S.G., Cruz J.M., Bora N.S., Garen A., Kaplan H.J. Immunotherapy for choroidal neovascularization in a laser-induced mouse model simulating exudative (wet) macular degeneration. Proc. Natl. Acad. Sci. U. S. A. 2003, 100(5):2679-2684.
9. Calabrese A., Bernard J.B., Hoffart L., Faure G., Barouch F., Conrath J., Castet E. Wet versus dry age-related macular degeneration in patients with central field loss: different effects on maximum reading speed. Investig. Ophthalmol. Vis. Sci. 2011, 52(5):2417-2424.
10. Campochiaro P.A. Retinal and choroidal neovascularization. J.Cell. Physiol. 2000, 184(3):301-310.
11. Cho Y., Cao X., Shen D., Tuo J., Parver L.M., Rickles F.R., Chan C.C. Evidence for enhanced tissue factor expression in age-related macular degeneration. Lab. Investig. 2011, 91(4):519-526.
12. Chu A.J. Tissue factor upregulation drives a thrombosis-inflammation circuit in relation to cardiovascular complications. Cell Biochem. Funct. 2006, 24(2):173-192.
13. Croce K., Libby P. Intertwining of thrombosis and inflammation in atherosclerosis. Curr. Opin. Hematol. 2007, 14(1):55-61.
14. Darmoul D., Gratio V., Devaud H., Lehy T., Laburthe M. Aberrant expression and activation of the thrombin receptor protease-activated receptor-1 induces cell proliferation and motility in human colon cancer cells. Am. J. Pathol. 2003, 162(5):1503-1513.
15. Green W.R. Clinicopathologic studies of treated choroidal neovascular membranes. A review and report of two cases. Retina 1991, 11(3):328-356.
16. Grossniklaus H.E., Ling J.X., Wallace T.M., Dithmar S., Lawson D.H., Cohen C., Elner V.M., Elner S.G., Sternberg P. Macrophage and retinal pigment epithelium expression of angiogenic cytokines in choroidal neovascularization. Mol. Vis. 2002, 8:119-126.
17. Gu L., Chen H., Tuo J., Gao X., Chen L. Inhibition of experimental choroidal neovascularization in mice by anti-VEGFA/VEGFR2 or non-specific siRNA. Exp. Eye Res. 2010, 91(3):433-439.
18. Harlos K., Martin D.M., O'Brien D.P., Jones E.Y., Stuart D.I., Polikarpov I., Miller A., Tuddenham E.G., Boys C.W. Crystal structure of the extracellular region of human tissue factor. Nature 1994, 370(6491):662-666.
19. Heier J.S., Brown D.M., Chong V., Korobelnik J.F., Kaiser P.K., Nguyen Q.D., Kirchhof B., Ho A., Ogura Y., Yancopoulos G.D., Stahl N., Vitti R., Berliner A.J., Soo Y., Anderesi M., Groetzbach G., Sommerauer B., Sandbrink R., Simader C., Schmidt-Erfurth U. Intravitreal aflibercept (VEGF trap-eye) in wet age-related macular degeneration. Ophthalmology 2012, 119(12):2537-2548.
20. Hembrough T.A., Swartz G.M., Papathanassiu A., Vlasuk G.P., Rote W.E., Green S.J., Pribluda V.S. Tissue factor/factor VIIa inhibitors block angiogenesis and tumor growth through a nonhemostatic mechanism. Cancer Res. 2003, 63(11):2997-3000.
21. Hollyfield J.G., Bonilha V.L., Rayborn M.E., Yang X., Shadrach K.G., Lu L., Ufret R.L., Salomon R.G., Perez V.L. Oxidative damage-induced inflammation initiates age-related macular degeneration. Nat. Med. 2008, 14(2):194-198.
22. Lu F., Hu Z., Sinard J., Garen A., Adelman R.A. Factor VII-verteporfin for targeted photodynamic therapy in a rat model of choroidal neovascularization. Investig. Ophthalmol. Vis. Sci. 2009, 50(8):3890-3896.
23. Mueller B.M., Reisfeld R.A., Edgington T.S., Ruf W. Expression of tissue factor by melanoma cells promotes efficient hematogenous metastasis. Proc. Natl. Acad. Sci. U. S. A. 1992, 89(24):11832-11836.
24. Nagai N., Oike Y., Izumi-Nagai K., Urano T., Kubota Y., Noda K., Ozawa Y., Inoue M., Tsubota K., Suda T., Ishida S. Angiotensin II type 1 receptor-mediated inflammation is required for choroidal neovascularization. Arterioscler. Thromb. Vasc. Biol. 2006, 26(10):2252-2259.
25. Ngo C.V., Picha K., McCabe F., Millar H., Tawadros R., Tam S.H., Nakada M.T., Anderson G.M. CNTO 859, a humanized anti-tissue factor monoclonal antibody, is a potent inhibitor of breast cancer metastasis and tumor growth in xenograft models. Int. J. Cancer 2007, 120(6):1261-1267.
26. Pendurthi U.R., Allen K.E., Ezban M., Rao L.V. Factor VIIa and thrombin induce the expression of Cyr61 and connective tissue growth factor, extracellular matrix signaling proteins that could act as possible downstream mediators in factor VIIa x tissue factor-induced signal transduction. J.Biol. Chem. 2000, 275(19):14632-14641.
27. Peng W., Yu Y., Li T., Zhu Y., Chen H. The effects of small interfering RNA-targeting tissue factor on an invitro model of neovascularization. Mol. Vis. 2013, 19:1296-1303.
28. Rak J., Milsom C., May L., Klement P., Yu J. Tissue factor in cancer and angiogenesis: the molecular link between genetic tumor progression, tumor neovascularization, and cancer coagulopathy. Semin. Thromb. Hemost. 2006, 32(1):54-70.
29. Rong Y., Hu F., Huang R., Mackman N., Horowitz J.M., Jensen R.L., Durden D.L., Van Meir E.G., Brat D.J. Early growth response gene-1 regulates hypoxia-induced expression of tissue factor in glioblastoma multiforme through hypoxia-inducible factor-1-independent mechanisms. Cancer Res. 2006, 66(14):7067-7074.
30. Ruf W., Disse J., Carneiro-Lobo T.C., Yokota N., Schaffner F. Tissue factor and cell signalling in cancer progression and thrombosis. J.Thromb. Haemost. 2011, 9(Suppl.1):306-315.
31. Ryan S.J. The development of an experimental model of subretinal neovascularization in disciform macular degeneration. Trans. Am. Ophthalmol. Soc. 1979, 77:707-745.
32. Sakurai E., Anand A., Ambati B.K., van Rooijen N., Ambati J. Macrophage depletion inhibits experimental choroidal neovascularization. Investig. Ophthalmol. Vis. Sci. 2003, 44(8):3578-3585.
33. Schlingemann R.O. Role of growth factors and the wound healing response in age-related macular degeneration. Graefes Arch. Clin. Exp. Ophthalmol. 2004, 242(1):91-101.
34. Seo M.S., Kwak N., Ozaki H., Yamada H., Okamoto N., Yamada E., Fabbro D., Hofmann F., Wood J.M., Campochiaro P.A. Dramatic inhibition of retinal and choroidal neovascularization by oral administration of a kinase inhibitor. Am. J. Pathol. 1999, 154(6):1743-1753.
35. Smith W., Assink J., Klein R., Mitchell P., Klaver C.C., Klein B.E., Hofman A., Jensen S., Wang J.J., de Jong P.T. Risk factors for age-related macular degeneration: pooled findings from three continents. Ophthalmology 2001, 108(4):697-704.
36. Spaide R.F., Chang L.K., Klancnik J.M., Yannuzzi L.A., Sorenson J., Slakter J.S., Freund K.B., Klein R. Prospective study of intravitreal ranibizumab as a treatment for decreased visual acuity secondary to central retinal vein occlusion. Am. J. Ophthalmol. 2009, 147(2):298-306.
37. Swaroop A., Chew E.Y., Rickman C.B., Abecasis G.R. Unraveling a multifactorial late-onset disease: from genetic susceptibility to disease mechanisms for age-related macular degeneration. Annu. Rev. Genomics Hum. Genet. 2009, 10:19-43.
38. Takehana Y., Kurokawa T., Kitamura T., Tsukahara Y., Akahane S., Kitazawa M., Yoshimura N. Suppression of laser-induced choroidal neovascularization by oral tranilast in the rat. Investig. Ophthalmol. Vis. Sci. 1999, 40(2):459-466.
39. Tezel T.H., Bodek E., Sonmez K., Kaliappan S., Kaplan H.J., Hu Z., Garen A. Targeting tissue factor for immunotherapy of choroidal neovascularization by intravitreal delivery of factor VII-Fc chimeric antibody. Ocul. Immunol. Inflamm. 2007, 15(1):3-10.
40. Tobe T., Ortega S., Luna J.D., Ozaki H., Okamoto N., Derevjanik N.L., Vinores S.A., Basilico C., Campochiaro P.A. Targeted disruption of the FGF2 gene does not prevent choroidal neovascularization in a murine model. Am. J. Pathol. 1998, 153(5):1641-1646.
41. Uusitalo-Jarvinen H., Kurokawa T., Mueller B.M., Andrade-Gordon P., Friedlander M., Ruf W. Role of protease activated receptor 1 and 2 signaling in hypoxia-induced angiogenesis. Arterioscler. Thromb. Vasc. Biol. 2007, 27(6):1456-1462.
42. Valmaggia C., Niederberger H., Lang C., Kloos P., Haueter I. The treatment of choroidal neovascularisation with intravitreal injections of bevacizumab (Avastin). Klin. Monbl Augenheilkd. 2008, 225(5):380-384.
43. Wang G.F., Zou X.L. Tissue factor with age-related macular degeneration. Int. J. Ophthalmol. 2012, 5(5):609-613.
44. Wickremasinghe S.S., Xie J., Lim J., Chauhan D.S., Robman L., Richardson A.J., Hageman G., Baird P.N., Guymer R. Variants in the APOE gene are associated with improved outcome after anti-VEGF treatment for neovascular AMD. Investig. Ophthalmol. Vis. Sci. 2011, 52(7):4072-4079.
45. Xie P., Kamei M., Suzuki M., Matsumura N., Nishida K., Sakimoto S., Sakaguchi H. Suppression and regression of choroidal neovascularization in mice by a novel CCR2 antagonist, INCB3344. PLoS One 2011, 6(12):e28933.
46. Xie P., Zhang W., Yuan S., Chen Z., Yang Q., Yuan D., Wang F., Liu Q. Suppression of experimental choroidal neovascularization by curcumin in mice. PLoS One 2012, 7(12):e53329.
47. Yoshida T., Ohno-Matsui K., Yasuzumi K., Kojima A., Shimada N., Futagami S., Tokoro T., Mochizuki M. Myopic choroidal neovascularization: a 10-year follow-up. Ophthalmology 2003, 110(7):1297-1305.
48. Zhang J., Ding J., Zhang X., Shao X., Hao Z. Regulation of vascular endothelial growth factor (VEGF) production and angiogenesis by tissue factor (TF) in SGC-7901 gastric cancer cells. Cancer Biol. Ther. 2005, 4(7):769-772.